Bank of New York Mellon Corp - EXAGEN INC ownership

EXAGEN INC's ticker is XGN and the CUSIP is 30068X103. A total of 54 filers reported holding EXAGEN INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of EXAGEN INC
ValueSharesWeighting
Q1 2022$208,000
-32.2%
25,917
-1.8%
0.00%
Q4 2021$307,000
-29.4%
26,396
-17.5%
0.00%
Q3 2021$435,000
+4.6%
32,004
+15.4%
0.00%
Q2 2021$416,000
+95.3%
27,739
+127.9%
0.00%
Q1 2021$213,000
+16.4%
12,170
-12.3%
0.00%
Q4 2020$183,000
+16.6%
13,872
-4.2%
0.00%
Q3 2020$157,000
-15.6%
14,479
-3.6%
0.00%
Q2 2020$186,00015,0180.00%
Other shareholders
EXAGEN INC shareholders Q3 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,037,074$2,520,0900.84%
PERKINS CAPITAL MANAGEMENT INC 259,905$6320.60%
COWEN AND COMPANY, LLC 943,552$2,292,8310.27%
Penbrook Management LLC 74,010$179,8440.14%
RTW INVESTMENTS, LP 1,391,184$3,380,5770.07%
Nantahala Capital Management 132,613$322,2500.02%
WASATCH ADVISORS LP 1,000,561$2,431,3630.02%
First Bank & Trust 16,793$40,8070.01%
SILVERCREST ASSET MANAGEMENT GROUP LLC 502,615$1,221,3540.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,300$114,9390.00%
View complete list of EXAGEN INC shareholders